×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
PD5-6: Comparison of clear petra and navigator HD ureteral access sheath in retrograde intra-renal surgery: a single center experience
2019-06-27
PD5-5: The impact of climate factors on the prevalence of urolithiasis among patients with or without hyperuricemia
2019-06-27
PD5-4: How we make the retrograde intrarenal surgery an easier operation
2019-06-27
PD5-3: Silodosin oral therapy facilitates stone clearance after shockwave lithotripsy for renal and ureteral calculi: a double-blind, randomized placebo-controlled study
2019-06-27
PD5-2: Comparison of stone-free rate between percutaneous nephrolithotomy and retrograde intrarenal surgery
2019-06-27
PD5-1: Using the novel “structural equation modeling” to analyze factors and pathways on the development of uric acid nephrolithiasis
2019-06-27
PD4-6: Biopsy grade group 1: underestimation and outcomes after RaLRP
2019-06-27
PD4-5: Pathological staging prediction rate of mpMRI in prostate cancer- CMUH experience
2019-06-27
PD4-4: Heteronemin exhibited cytotoxic effects in prostate cancer cells via oxidative and ER stress involved by protein tyrosine phosphatases activation
2019-06-27
PD4-3: Analysis of biochemical recurrence among pathology T2+ patients with prostate cancer
2019-06-27
PD4-2: Tumor-originated exosomal prothymosin-α triggers muscle wasting in bladder cancers
2019-06-27
PD4-1: Identification, propagation and characterisation of circulating renal cancer stem cells
2019-06-27
PD3-6: The role of RENAL, PADUA, C-index, CSA nephrometry systems in predicting individual renal function after partial nephrectomy
2019-06-27
PD3-5: Prognostic value of USP2 overexpression in upper tract urothelial carcinomas in Taiwan.
2019-06-27
PD3-4: Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan, direct comparison from Taiwan-Japan UTUC collaboration cohort.
2019-06-27
PD3-3: Miconazole, an anti-fungal agent, exerts bladder cancer chemoprevention by NRF2 activation
2019-06-27
PD3-2: Overexpression of SRC is associated with epithelial mesenchymal transition, invadopodia formation, drug resistant and stemness characters in urothelial carcinoma
2019-06-27
PD3-1: Cis-platinum induce PD-L1 expression through ERK/AP-1 signal cascade in bladder cancer cells
2019-06-27
PD2-6: Robot-assisted radical cystectomy with neobladder reconstruction:single center experience and outcome
2019-06-27
PD2-5: Laparoendoscopic single-site (LESS) nephroureterectomy, will robotic assist really help? a single hospital experience
2019-06-27
PD2-4: Comparison of the surgical and functional outcomes for clinically benign versus malignant renal tumor after minimally invasive partial nephrectomy
2019-06-27
PD2-3: Robotic radical cystectomy with intracorporeal neo-bladder reconstruction-CMUH experience
2019-06-27
PD2-2: Robotic-assisted radical cystectomy: experience of a single institution
2019-06-27
PD2-1: Robot-assisted and pure laparoscopic prostatectomy in high risk prostate cancer: TCVGH single team experience
2019-06-27
<
68
69
70
71
72
73
74
75
76
77
>
/ 127